Eva
Gerdts
Professor
Visit Address:
Haukeland universitetssykehus, Laboratoriebygget
5021 Bergen
Postal Address:
Postboks 7804
5021 Bergen
Phone:
+47 55 97 22 20
E-mail:
Journal articles
- 2014. Four-group classifcation of left ventricular hypertrophy based on ventricular concentricity and dilatation identifes a low-risk subset of eccentric hypertrophy in hypertensive patients. Circulation Cardiovascular Imaging. 7: 422-429. doi: 10.1161/CIRCIMAGING.113.001275
- 2014. Determinants of systolic blood pressure response during exercise in overweight subjects. Blood Pressure. 23: 200-205. doi: 10.3109/08037051.2013.858477
- 2014. Prevalence and covariates of abnormal left ventricular geometry in never-treated hypertensive patients in Tanzania. Blood Pressure. 23: 21-38. doi: 10.3109/08037051.2013.791415
- 2014. Indexing aortic valve area by body surface area increases the prevalence of severe aortic stenosis. Heart. 100: 28-33. doi: 10.1136/heartjnl-2013-304443
- 2014. Iatrogenic external pudendal artery pseudoaneurysm with a communicating arteriovenous fistula - A diagnostic and therapeutic pitfall. Echocardiography. 31: E158-E160. doi: 10.1111/echo.12560
- 2014. No gender difference in the extent of myocardial ischemia in non-ST elevation myocardial infarction. European Journal of Preventive Cardiology. 21: 123-129. doi: 10.1177/2047487312454107
- 2014. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment (the LIFE study). Blood Pressure. 23: 206-212. doi: 10.3109/08037051.2013.858482
- 2014. Adjusting parameters of aortic valve stenosis severity by body size. Heart. 100: 1024-1030. doi: 10.1136/heartjnl-2013-305225
- 2014. Impact of obesity and nonobesity on grading the severity of aortic valve stenosis. American Journal of Cardiology. 113: 1532-1535. doi: 10.1016/j.amjcard.2014.01.429
- 2013. Prognostic Value of Energy Loss Index in Asymptomatic Aortic Stenosis. Circulation. 127: 1149-1156. doi: 10.1161/CIRCULATIONAHA.112.078857
- 2013. Systolic left ventricular function according to left ventricular concentricity and dilatation in hypertensive patients: the Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension. 31: 2060-2068. doi: 10.1097/HJH.0b013e328362bbd6
- 2013. Left atrial volume index as a marker of left ventricular diastolic dysfunction in asymptomatic Tanzanian diabetic patients. Blood Pressure. 22: 86-93. doi: 10.3109/08037051.2012.707351
- 2013. Left atrial volume as predictor of valve replacement and cardiovascular events in patients with asymptomatic mild to moderate aortic stenosis. Echocardiography. 30: 1008-1014. doi: 10.1111/echo.12184
- 2013. Mitral annular calcification and incident ischemic stroke in treated hypertensive patients: The LIFE study. American Journal of Hypertension. 26: 567-573. doi: 10.1093/ajh/hps082
- 2013. Coronary artery plaque burden is a predictor of myocardial ischemia in non-ST elevation myocardial infarction in both genders. European Heart Journal. 34: 74-75.
- 2013. The Norwegian stroke in the young study (NOR-SYS): rationale and design. BMC Neurology. 13. 12 pages. doi: 10.1186/1471-2377-13-89
- 2013. Arterial Stiffness Is Associated With Abnormal Left Ventricular Geometry In Patients With Rheumatoid Arthritis. Arthritis and Rheumatism. 65: S174-S175.
- 2013. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 23: 122-129. doi: 10.1016/j.numecd.2011.03.008
- 2013. Natural history of mild and of moderate aortic stenosis-new insights from a large prospective European study. Current problems in cardiology. 38: 365-409. doi: 10.1016/j.cpcardiol.2013.06.003
- 2013. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. International Journal of Cardiology. 166: 72-76. doi: 10.1016/j.ijcard.2011.09.064
- 2013. Hypertensive target organ damage predicts incident diabetes mellitus. European Heart Journal. 34: 3419-3426. doi: 10.1093/eurheartj/eht281
- 2013. Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. The Lancet. 14 pages. doi: 10.1016/S0140-6736(13)61836-X
- 2013. Impact of isolated systolic hypertension on normalization of left ventricular structure during antihypertensive treatment in patients with electrocardiographic left ventricular hypertrophy (LIFE). European Heart Journal. 34: 597-597.
- 2013. Disease Activity In Rheumatoid Arthritis Is Associated With Abnormal Left Ventricular Geometry. Arthritis and Rheumatism. 65: S182-S182.
- 2013. Does rheumatoid arthritis predispose to abnormal left ventricular geometry independent of hypertension? European Heart Journal. 34: 754-754.
- 2013. Outcome in 1763 asymptomatic patients with mild or moderate calcific aortic stenosis followed prospectively with annual echocardiography. European Heart Journal. 34: 334-334.
- 2013. Effect of overweight and obesity on cardiovascular events in asymptomatic aortic stenosis. Journal of the American College of Cardiology. 62: 1683-1690. doi: 10.1016/j.jacc.2013.04.081
- 2013. Left ventricular geometry in obesity: Is it what we expect? NMCD. Nutrition Metabolism and Cardiovascular Diseases. 23: 905-912. doi: 10.1016/j.numecd.2013.06.012
- 2012. Arterial stiffness is associated with carotid atherosclerosis in hypertensive patients (The Campania Salute Network). American Journal of Hypertension. 25: 739-745. doi: 10.1038/ajh.2012.38
- 2012. Increased relative wall thickness is a marker of subclinical cardiac target-organ damage in African diabetic patients. Cardiovascular Journal of Africa. 23: 435-441. doi: 10.5830/CVJA-2012-023
- 2012. Proper Use of Left Atrial Ejection Force as a Measure of Left Atrial Mechanical Function Reply. Echocardiography. 29: 881-882.
- 2012. Left Atrial Systolic Force and Outcome in Asymptomatic Mild to Moderate Aortic Stenosis. Echocardiography. 29: 1038-1044. doi: 10.1111/j.1540-8175.2012.01744.x
- 2012. Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. Journal of Hypertension. 30: 421-428. doi: 10.1097/HJH.0b013e32834f0b00
- 2012. Midwall left ventricular systolic function in asymptomatic aortic valve stenosis: is it prognostically important? The SEAS study. European Heart Journal. 33: 97-98.
- 2012. Effect of bariatric surgery on left ventricular geometry and function in severe obesity. Obesity Research and Clinical Practice. 6: E189-E196. doi: 10.1016/j.orcp.2012.02.008
- 2012. Left atrial enlargement - A prevalent marker of hypertensive heart disease. Blood Pressure. 21: 71-72. doi: 10.3109/08037051.2012.677511
- 2012. Covariates of global longitudinal strain and displacement in type 2 diabetes: a speckle tracking echocardiography study. European Heart Journal. 33: 454-454.
- 2012. Association of heart failure hospitalizations with combined electrocardiography and ehocardiography criteria for left ventricular hypertrophy. American Journal of Hypertension. 25: 678-683. doi: 10.1038/ajh.2012.31
- 2012. Impact of QRS duration and morphology on the risk of sudden cardiac death in asymptomatic patients with aortic stenosis the SEAS (Simvastatin and Ezetimibe in aortic stenosis) study. Journal of the American College of Cardiology. 59: 1142-1149. doi: 10.1016/j.jacc.2011.12.020
- 2012. Contrasting hemodynamic mechanisms of losartan- vs. atenolol-based antihypertensive treatment: A LIFE study. American Journal of Hypertension. 25: 1017-1023. doi: 10.1038/ajh.2012.81
- 2012. Left ventricular function in children and adults after renal transplantation in childhood. Pediatric nephrology (Berlin, West). 27: 1565-1574. doi: 10.1007/s00467-012-2167-z
- 2012. A risk score for predicting mortality in patients with asymptomatic mild to moderate aortic stenosis. Heart. 98: 377-383. doi: 10.1136/heartjnl-2011-300475
- 2012. Femoral pseudoaneurysm with a communicating arteriovenous fistula: a complication after percutaneous coronary intervention. Circulation. 126: E161-E162. doi: 10.1161/CIRCULATIONAHA.112.102228
- 2012. Hypertension in Aortic Stenosis Implications for Left Ventricular Structure and Cardiovascular Events. Hypertension. 60: 90-97. doi: 10.1161/HYPERTENSIONAHA.112.194878
- 2012. Global left ventricular load in asymptomatic aortic stenosis: covariates and prognostic implication (the SEAS trial). Cardiovascular Ultrasound. 10. doi: 10.1186/1476-7120-10-43
- 2011. Aortic root geometry in aortic stenosis patients (a SEAS substudy). European Journal of Echocardiography. 12: 585-590. doi: 10.1093/ejechocard/jer037
- 2011. Left atrial systolic force in asymptomatic ortic stenosis. Echocardiography. 28: 968-977. doi: 10.1111/j.1540-8175.2011.01488.x
- 2011. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart. 97: 301-307. doi: 10.1136/hrt.2010.192997
- 2011. Impact of aortic valve stenosis and hypertension on radial strain in multiple layers. European Heart Journal, Supplement. 32: 1008-1009.
- 2011. Impact of valvuloarterial impedance on cardiovascular outcome in patients with asymptomatic aortic stenosis. The SEAS study. Circulation. 124.
- 2011. Increased systolic strain rate early after transcatheter aortic valve implantation. European Journal of Echocardiography. 12: ii37-ii37. doi: 10.1093/ejechocard/jer206
- 2011. Differences in cardiovascular risk profile between electrocardiographic hypertrophy versus strain in asymptomatic patients with aortic stenosis (from SEAS data). American Journal of Cardiology. 108: 541-547. doi: 10.1016/j.amjcard.2011.03.084
- 2011. Prognostic importance of atrial fibrillation in asymptomatic aortic stenosis: The Simvastatin and Ezetimibe in Aortic Stenosis study. International Journal of Cardiology. doi: 10.1016/j.ijcard.2011.09.064
- 2011. Outcome of patients with low-gradient "severe" aortic stenosis and preserved ejection fraction. Circulation. 123: 887-895. doi: 10.1161/CIRCULATIONAHA.110.983510
- 2011. Response to Letters Regarding Article, "Outcome of Patients With Low-Gradient "Severe" Aortic Stenosis and Preserved Ejection Fraction". Circulation. 124: E362-E363. doi: 10.1161/CIRCULATIONAHA.111.045203
- 2011. In-treatment stroke volume predicts cardiovascular risk in hypertension. Journal of Hypertension. 29: 1508-1514. doi: 10.1097/HJH.0b013e32834921fb
- 2011. Contrast stress echocardiography in hypertensive heart disease. Cardiovascular Ultrasound. 9. doi: 10.1186/1476-7120-9-33
- 2011. Usefulness of contrast echocardiography for predicting the severity of angiographic coronary disease in non-ST-elevation myocardial infarction. American Journal of Cardiology. 107: 1262-1267. doi: 10.1016/j.amjcard.2010.12.034
- 2011. Left atrial size in hypertension and stroke. Journal of Hypertension. 29: 1988-1993. doi: 10.1097/HJH.0b013e32834a98db
- 2010. Impact of Pressure Recovery on Echocardiographic Assessment of Asymptomatic Aortic Stenosis: A SEAS Substudy. Journal of the American College of Cardiology. 3: 555-562. doi: 10.1016/j.jcmg.2009.11.019
- 2010. Increased Relative Wall Thickness - A Frequent Marker of Subclinical Cardiac Target Organ Damage in African Diabetic Patients. Journal of Hypertension. 28: E357-E357.
- 2010. Hypokalemi blunts left ventricular mass regression in hypertensive patients during losartan- or atenolol-based treatmend: The LIFE echo-substudy. Journal of Hypertension. 28: E442-E443.
- 2010. Are coronary revascularization and myocardial infarction a homogeneous combined endpoint in hypertension trials? The Losartan Intervention For Endpoint reduction in hypertension study. Journal of Hypertension. 28: 1134-1140. doi: 10.1097/HJH.0b013e328337a9c8
- 2010. Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases. Experimental and clinical cardiology. 15: e45-e51.
- 2010. Severe obstructive sleep apnea elicits concentric left ventricular geometry. Journal of Hypertension. 28: 1074-1082. doi: 10.1097/HJH.0b013e328336c90a
- 2010. Myocardial deformation in aortic valve stenosis – relation to left ventricular geometry. Heart. 96: 106-112. doi: 10.1136/hrt.2009.172569
- 2010. An unusual location of a papillary fibroelastoma. European Journal of Echocardiography. 11. doi: 10.1093/ejechocard/jep197
- 2010. Left ventricular mass, an independent predictor of morbidity and mortality in aortic valve stenosis. European Heart Journal. 31: 887-887.
- 2010. COMBINED USE OF ELECTROCARDIOGRAM AND ECHOCARDIOGRAM TO BETTER IDENTIFY HYPERTENSIVE PATIENTS AT HIGH RISK FOR HEART FAILURE. Journal of Hypertension. 28: E214-E214.
- 2010. Impact of Baseline Severity of Aortic Valve Stenosis on Effect of Intensive Lipid Lowering Therapy (from the SEAS Study). American Journal of Cardiology. 106: 1634-1639. doi: 10.1016/j.amjcard.2010.07.042
- 2010. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in aortic stenosis [SEAS] substudy). American Journal of Cardiology. 105: 1456-1460. doi: 10.1016/j.amjcard.2009.12.069
- 2010. Impact of ultrasound contrast agents in echocardiographic assessment of ischemic heart disease. Recent patents on cardiovascular drug discovery. 5: 103-112. doi: 10.2174/157489010791515403
- 2010. Hypoperfusion by contrast echocardiography predicts coronary artery disease severity in non-ST elevation myocardial infarction. European Heart Journal. 31: 914-914.
- 2010. Relationship of left atrial enlargement to persistence or development of ECG left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. Journal of Hypertension. 28: 1534-1540. doi: 10.1097/HJH.0b013e328338c20e
- 2010. Impact of hypertension on left ventricular structure in patients with asymptomatic aortic valve stenosis (a SEAS substudy). Journal of Hypertension. 28: 377-383. doi: 10.1097/HJH.0b013e328332fa44
- 2010. Risk factors for unexpected sudden death in patients with non-symptomatic aortic stenosis (the SEAS study). European Heart Journal. 31: 886-887.
- 2010. Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). Blood Pressure. 19: 140-144. doi: 10.3109/08037051.2010.481816
- 2010. In-treatment midwall and endocardial fractional shortening predict cardiovascular outcome in hypertensive patients with preserved baseline systolic ventricular function: the Losartan Intervention For Endpoint reduction study. Journal of Hypertension. 28: 1541-1546. doi: 10.1097/HJH.0b013e328339f943
- 2010. Prognostic Significance of Left Ventricular Diastolic Dysfunction in Patients With Left Ventricular Hypertrophy and Systemic Hypertension (the LIFE Study). American Journal of Cardiology. 106: 999-1005. doi: 10.1016/j.amjcard.2010.05.032
- 2010. In-treatment reduced left atrial diameter during antihypertensive treatment is associated with reduced new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Blood Pressure. 19: 169-175. doi: 10.3109/08037051.2010.481811
- 2009. Exercise and cardiovascular outcomes in hypertensive patients in relation to structure and function of left ventricular hypertrophy: the LIFE study. European Journal of Cardiovascular Prevention & Rehabilitation. 16: 242-248. doi: 10.1097/HJR.0b013e328329560e
- 2009. Development of Systolic Dysfunction Not Related to Myocardial Infarction in Treated Hypertensive Patients With Left Ventricular Hypertrophy: The LIFE Echo Substudy. Circulation. 120: S1164-S1165.
- 2009. Mitral E Wave Deceleration Time to Peak E Velocity Ratio and Cardiovascular Outcome in Hypertensive Patients During Antihypertensive Treatment (from the LIFE Echo-Substudy). American Journal of Cardiology. 104: 1098-1104. doi: 10.1016/j.amjcard.2009.05.063
- 2009. Compensatory or inappropriate left ventricular mass in asymptomatic aortic stenosis. Journal of the American College of Cardiology. 53: A408-A409. doi: 10.1016/j.jacc.2009.01.021
- 2009. Relation of degree of aortic valve calcification to left ventricular geometry and systolic function in asymptomatic aortic valve stenosis: A SEAS substudy. Journal of the American College of Cardiology. 53: A410-A410. doi: :10.1016/j.jacc.2009.01.021
- 2009. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS Substudy. JACC Cardiovascular Imaging. 2: 390-399.
- 2009. Low-Flow Aortic Stenosis in Asymptomatic Patients Valvular-Arterial Impedance and Systolic Function From the SEAS Substudy. Journal of the American College of Cardiology. 2: 390-399. doi: 10.1016/j.jcmg.2008.12.021
- 2009. 2D Longitudinal Myocardial Strain: A More Sensitive Parameter of Left Ventricular Dysfunction in Aortic Valve Stenosis? Circulation. 120: S372-S373.
- 2009. Left ventricular long-axis function in treated haemochromatosis. International Journal of Cardiac Imaging. 25: 237-247. doi: 10.1007/s10554-008-9383-4
- 2009. Left ventricular diastolic function in patients with treated haemochromatosis. Scandinavian Cardiovascular Journal. 43: 32-38. doi: 10.1080/14017430802203811
- 2009. Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 634-640.
- 2009. Pulse pressure, left ventricular function and cardiovascular events during antihypertensive treatment (the LIFE study). Blood Pressure. 18: 180-186. doi: 10.1080/08037050903047202
- 2009. Impact of diabetes on treatment-induced changes in left ventricular structure and function in hypertensive patients with left ventricular hypertrophy. The LIFE study. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 19: 306-312. doi: 10.1016/j.numecd.2008.12.009
- 2009. Impact of severity of aortic valve stenosis on effect of intensive lipid-lowering therapy: The SEAS study. Journal of the American College of Cardiology. 53: A415-A415. doi: 10.1016/j.jacc.2009.01.021
- 2009. Outcome of Asymptomatic Patients With Low Gradient "Severe" Aortic Valve Stenosis and Preserved Ejection Fraction - Results From the Prospective SEAS Study. Circulation. 120: S371-S371.
- 2009. Myocardial Contrast Echocardiography in Assessment of Stable Coronary Artery Disease at Intermediate Dobutamine-Induced Stress Level. Echocardiography. 26: 52-60. doi: 10.1111/j.1540-8175.2008.00738.x
- 2009. IMPACT OF STROKE VOLUME ON CARDIOVASCULAR RISK IN HYPERTENSIVE PATIENTS WITH ELECTROCARDIOGRAPHIC LEFT VENTRICULAR HYPERTROPHY (A LIFE SUBSTUDY). Journal of Hypertension. 27: S319-S320.
- 2009. Ultrasound in evaluation of post-interventional femoral vein obstruction: a case report. Cardiovascular Ultrasound. 7: 14. doi: 10.1186/1476-7120-7-14
- 2009. Quantitative contrast stress echocardiography in assessment of restenosis after percutaneous coronary intervention in stable coronary artery disease. European Journal of Echocardiography. 10: 858-864. doi: :10.1093/ejechocard/jep090
- 2009. Gender Differences in Outcome During Antihypertensive Therapy in Relation to Regression of Electrocardiographic Left Ventricular Hypertrophy: The LIFE Study. Circulation. 120: S1111-S1111.
- 2009. ISOLATED SYSTOLIC HYPERTENSION IN PATIENTS WITH ASYMPTOMATIC AORTIC STENOSIS (A SEAS SUBSTUDY). Journal of Hypertension. 27: S248-S248.
- 2009. Aortic valve stenosis. The Lancet. 373: 2022-2023.
- 2009. Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study. NMCD. Nutrition Metabolism and Cardiovascular Diseases. 19: 634-640. doi: 10.1016/j.numecd.2008.12.012
- 2008. Impact of Pressure Recovery on Diagnosis of Severe Aortic Stenosis In Asymptomatic Patients. (A SEAS Substudy). Circulation. 118: S931-S931.
- 2008. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Hypertension. 26: 1472-1476.
- 2008. Clinical impact of ' in-treatment' wall motion abnormalities in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Hypertension. 26: 806-812.
- 2008. Impact of global afterload on left ventricular myocardial contractility in asymptomatic aortic stenosis: A SEAS substudy. Journal of the American College of Cardiology. 51: A380-A380.
- 2008. The differential impact of static and pulsatile blood pressure components on regional myocardial deformation in patients with asymptomatic aortic valve stenosis. A SEAS substudy. Journal of Hypertension. 26: S255-S256.
- 2008. Factors influencing left ventricular structure and stress-corrected systolic function in men and women with asymptomatic aortic valve stenosis (a SEAS substudy). American Journal of Cardiology. 101: 510-515. doi: 10.1016/j.amjcard.2007.09.100
- 2008. Left atrial volume in patients with asymptomatic aortic valve stenosis (the simvastatin and ezetimibe in aortic stenosis study). American Journal of Cardiology. 101: 1030-1034. doi: 10.1016/j.amjcard.2007.11.048
- 2008. Left ventricular structure in different types of chronic pressure overload. European Heart Journal, Supplement. 10: E23-E30. doi: 10.1093/eurheartj/sun015
- 2008. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). European Journal of Echocardiography. 9: 809-815. doi: 10.1093/ejechocard/jen155
- 2008. Gender differences in left ventricular structure and function during antihypertensive treatment - The Losartan intervention for Endpoint reduction in hypertension study. Hypertension. 51: 1109-1114. doi: 10.1161/HYPERTENSIONAHA.107.107474
- 2008. Gender differences in left ventricular structure and function during antihypertensive treatment (the LIFE study). Journal of Hypertension. 26: S275-S275.
- 2008. Prevalence and covariates of electrocardiographic left ventricular hypertrophy in diabetic patients in Tanzania. Cardiovascular Journal of Africa. 19: 8-14.
- 2008. Brain abscess caused by paradoxical embolization in Ebstein's anomaly. European Journal of Echocardiography. 9: 105-106. doi: 10.1016/j.euje.2007.03.032
- 2008. Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy in Response to Antihypertensive Therapy. Hypertension. 52: 100-106. doi: 10.1161/HYPERTENSIONAHA.108.110064
- 2008. Gender Differences in Regression of Electrocardiographic Left Ventricular Hypertrophy During Antihypertensive Therapy. Hypertension. 52: 100-106. doi: 10.1161/HYPERTENSIONAHA.108.110064
- 2008. Effects of Losartan in women with hypertension and left ventricular hypertrophy results from the Losartan Intervention For Endpoint Reduction in hypertension study. Hypertension. 51: 1103-1108. doi: 10.1161/HYPERTENSIONAHA.107.105296
- 2008. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. New England Journal of Medicine. 359: 1343-1356. doi: 10.1056/NEJMoa0804602
- 2007. Mitral E wave deceleration time to peak E velocity ratio and cardiovascular outcome in hypertensive patients during anti-hypertensive treatment: The LIFE echo-substudy. Circulation. 116: 498-498.
- 2007. Electrocardiographic and echocardiographic detection of myocardial infarction in patients with left-ventricular hypertrophy. American Journal of Hypertension. 20: 771-776. doi: 10.1016/j.amjhyper.2007.01.021
- 2007. Impact of left ventricular geometry on stress-corrected left ventricular systolic function in asymptomatic aortic valve stenosis. A SEAS substudy. Journal of the American College of Cardiology. 49: 298A-299A.
- 2007. Reduced exercise capacity in genetic haemochromatosis. European Journal of Cardiovascular Prevention & Rehabilitation. 14: 470-475. doi: 10.1097/HJR.0b013e3280ac151c
- 2007. Pulse pressure - An independent predictor of left ventricular hyperthrophy in patients with asymptomatic aortic stenosis. A SEAS substudy. Circulation. 116: 671-671.
- 2007. Left atrial size and risk of major cardiovascular events during antihypertensive treatment - Losartan intervention for endpoint reduction in hypertension trial. Hypertension. 49: 311-316. doi: 10.1161/01.HYP.0000254322.96189.85
- 2007. Association of aortic regurgitation with cardiovascular morbidity and mortality in hypertensive patients with left ventricle hypertrophy: The LIFE study. Circulation. 116: 735-735.
- 2007. Gender difference in the association of aortic valve sclerosis and cardiovascular events in hypertensive adults with left ventricular hypertrophy: The LIFE study. Circulation. 116: 735-735.
- 2007. Relationship of left ventricular Systolic function to persistence or development,of Electrocardiographic left ventricular hypertrophy in hypertensive patients: Implications for the development of new heart failure. Circulation. 116: 473-473.
- 2007. Design and baseline characteristics of the simvastatin and ezetimibe in aortic stenosis (SEAS) study. American Journal of Cardiology. 99: 970-973. doi: 10.1016/j.amjcard.2006.10.064
- 2007. Does metabolic syndrome influence reduction of ECG left ventricular hypertrophy? The LIFE study. Journal of Hypertension. 25: S78-S78.
- 2006. Impact of hypertension on left ventricular hypertrophy regression and exercise capacity in patients operated for aortic valve stenosis. Scandinavian Cardiovascular Journal. 40: 167-174.
- 2006. Prevalence and covariates of low left ventricular midwall shortening in patients with asymptomatic aortic valve stenosis. A SEAS substudy. Circulation. 114: 656-657.
- 2006. Impact of gender on left atrial and ventricular response to asymptornatic aortic valve stenosis. The SEAS study. Journal of the American College of Cardiology. 47: 285A-286A.
- 2006. Exercise performance during losartan- or atenolol-based treatment in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Blood Pressure. 15: 220-226. doi: 10.1080/08037050600911957
- 2006. Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy - The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. Circulation. 113: 1588-1596.
- 2006. Relationship of left atrial enlargement to persistence or development of electrocardiographic left ventricular hypertrophy in hypertensive patients: implications for the development of new atrial fibrillation. Circulation. 114: 366-366.
- 2005. Impact of gender on left ventricular geometery and function in mild and moderate asymptomatic aortic valve stenosis. The SEAS study. European Journal of Echocardiography. 6: S68.
- 2005. Female sex and effect of losartan versus atenolol in patients with hypertension and left ventricular hypertrophy. The LIFE study. Journal of the American College of Cardiology. 45.
- 2005. Relationship of electrocardiographic strain pattern to left ventricular diastolic function in hypertensive patients: The LIFE study. Journal of the American College of Cardiology. 45.
- 2005. Impact of concomitant hypertension on left ventricular structure in patients with aortic valve stenosis. The SEAS study. European Journal of Echocardiography. 6: S76.
- 2005. Influence of hypertension on angiographic findings in patients with angina pectoris. American Journal of Hypertension. 18: 175A.
- 2005. Echocardiographic determinants of new-onset atrial fibrillation in patients with hypertension and electrocardiographic left ventricular hypertrophy: The LIFE study. Journal of the American College of Cardiology. 45.
- 2005. Cardiovascular morbidity and mortality in hypertensive patients with a history of atrial fibrillation: The Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Journal of the American College of Cardiology. 45(5): 705-711.
- 2005. Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the Losartan Intervention For End Point Reduction in Hypertension (LIFE) study. Journal of the American College of Cardiology. 45(5): 712-719.
- 2004. Sex-related difference in regression of left ventricular hypertrophy with antihypertensive treatment: the LIFE study. Journal of Human Hypertension. 18: 411-416.
- 2004. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: The LIFE Study. Journal of the American College of Cardiology. 43: 357A.
- 2004. Tissue Doppler findings in patients with genetic hemochromatosis. Hjerteforum. 17: 101.
- 2004. Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol - The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation. 110: 1456-1462.
- 2004. Prognostic significance of left ventricular mass change during treatment of hypertension. Journal of the American Medical Association (JAMA). 292: 2350-2356.
- 2004. Ethnicity, left ventricular hypertrophy regressio and cardiovascular events in the LIFE echocardiography substudy. American Journal of Hypertension. 17: A195.
- 2004. Blood pressure and cardiovascular risk factors in hypertensive patients referred to a regional hospital in Ghana. American Journal of Hypertension. 17: A196.
- 2004. Hypertensjon og hjertesykdom. Tidsskrift for Den norske legeforening. 124: 802-805.
- 2004. Pulse pressure as cardiovascular risk marker during losartan or atenolol based therapy in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Trial). Journal of the American College of Cardiology. 43: 448A.
- 2004. Impact of age on left ventricular hypertrophy regression during antihypertensive treatment with losartan or atenolol (the LIFE study). Journal of Human Hypertension. 18: 417-422.
- 2004. Clinical and echocardiographic risk factors for congestive heart failure in controlled hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE Study). Circulation. 110: 682-682.
- 2004. Impact of valvular regurgitation on left ventricular geometry and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Human Hypertension. 18: 411-416.
- 2004. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study. Journal of Human Hypertension. 18: 397-402.
- 2004. Effect of losartan versus atenolol on aortic valve sclerosis (a LIFE substudy). American Journal of Cardiology. 94: 1076-1080.
- 2004. Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: a LIFE substudy. Journal of Human Hypertension. 18: 453-459.
- 2004. Essential hypertension in women. Blood Pressure. 13: 272-278.
- 2004. Essential hypertension in women. Blood Pressure. 13: 272-278.
- 2004. Usefulness of the assessment of the appropriateness of left ventricular mass to detect left ventricular systolic and diastolic abnormalities in absence of echocardiographic left ventricular hypertrophy: the LIFE study. Journal of Human Hypertension. 18: 423-430.
- 2004. Blood pressure measurements by the Keito machine. Evaluation versus office blood pressure by physicians. Blood Pressure Monitoring. 9: 167-172.
- 2004. Does losartan improve diastolic left ventricular function beetter than atenolol during more then four years of antihypertensive treatment? The LIFE Study. Circulation. 110: 637.
- 2004. Myocardial performance index independently predicts cardiovascular morbidity and mortality in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Journal of the American College of Cardiology. 43: 227A.
- 2004. Relation of impaired left ventricular filling to systolic midwall mechanics in hypertensive patients with normal left ventricular systolic chamber function: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study. American Heart Journal. 148: 538-544.
- 2003. Left ventricular mass regression in the life study: effect of previous antihypertensive treatment. American Journal of Hypertension. 16: 180-186.
- 2003. Hjertesykdom ved genetisk hemokromatose. Hjerteforum. 15: 16-20.
- 2003. Pulse pressure/stroke index and left ventricular geometry and function:the Life Study. Journal of Hypertension. 21: 781-787.
- 2003. Echocardiographic wall motion abnormalities in hypertensive patients with electrocardiograaphhic left ventricular hypertrophy The life study. Hypertension. 41: 75-82.
- 2002. Relation of left ventricular geometry and function to aortic root dilatation in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). American Journal of Cardiology. 89: 337-341.
- 2002. Progressive hypertrophy regression with sustained pressure reduction in hypertension: the Losartan Intervention For Endpoint Reduction study. Journal of Hypertension. 20: 1445-1450.
- 2002. Bruk av ekkokardiografi i hypertensjonsstudier. Hjerteforum. 15: 77-83.
- 2002. Impact of diastolic Doppler indices on exercise capacity in hypertensive patients with electrocardiographic left ventricular hypertrophy (a LIFE substudy). Journal of Hypertension. 20: 1223-1229.
- 2002. Sex differences in left ventricular systolic function. Cardiology Review. 19: 29-32.
- 2002. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Hypertension. 39: 739-743.
- 2002. Correlates of pulse pressure reduction during antihypertensive treatment (losartan or atenolol) in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). American Journal of Cardiology. 89: 399-402.
- 2002. Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study. Circulation. 105: 1071-1076.
- 2002. Urine albumin/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Losartan Intervention for Endpoint Reduction. American Heart Journal. 143: 319-326.
- 2002. Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study. Circulation. 106: 227-232.
- 2001. Relation of left ventricular geometry and function to systemic hemodynamics in hypertension: the LIFE Study. Journal of Hypertension. 19: 127-134.
- 2001. Echocardiographic left ventricular geometry in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. Blood Pressure. 10: 74-82.
- 2001. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). American Journal of Cardiology. 87: 980-983.
- 2001. Left ventricular function and hemodynamic features of inappropriate left ventricular hypertrophy in patients with systemic hypertension: the LIFE study. American Heart Journal. 141: 784-791.
- 2001. Similar effects of isolated systolic and combined hypertension on left ventricular geometry and function: the LIFE Study. American Journal of Hypertension. 14: 768-774.
- 2001. Renal hemodynamic effects of captopril and doxazosin during slight physical activity in hypertensive patients with type-1 diabetes mellitus. Kidney and Blood Pressure Research. 24: 64-70.
- 2000. Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. Journal of Hypertension. 18: 1129-1138.
- 2000. Left ventricular wall stresses and stress-mass products in hypertensive patients with electrocardiographic left ventricular hypertrophy. Journal of Hypertension. 18: 1129-1138.
- 2000. HOPE ett år senere. Hjerteforum. 13: 31-35.
- 2000. HOPE ett år senere. Hjerteforum. 13: 31-35.
- 2000. Long-term central hemodynamic effects at rest and during exercise of losartan in essential hypertension. American Heart Journal. 140: 624-630.
- 2000. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. Hypertension. 35: 6-12.
- 2000. Impact of different partition values on prevalences of left ventricular hypertrophy and concentric geometry in a large hypertensive population: the LIFE Study. Hypertension. 35: 6-12.
- 2000. Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. American Journal of Cardiology. 85: 466-472.
- 2000. Left ventricular diastolic filling patterns in hypertensive patients with electrocardiographic left ventricular hypertrophy: The LIFE Study. American Journal of Cardiology. 85: 466-472.
- 1999. Reproducibility of salt sensitivity testing using a dictary approach in essential hypertension. Journal of Human Hypertension. 13: 375-384.
- 1999. Early complications and long-term mortality after urgent or routine coronary angioplasty. Scandinavian Cardiovascular Journal. 51: 33.
- 1999. Similar central hemodynamics in salt sensitive and salt resistant hypertensive patients. Blood Pressure. 8: 233-241.
Reports and theses
- 1999. The influence of dietary salt intake on blood pressure and left ventricular mass in essential hypertension and hypertensive type-1 diabetic patients. Dr.med.. -. Norwegian Society of Cardiology [utgitt i: Hjerteforum 1999;12(Suppl.1):1-103], Oslo. 94 pages.
More information in national current research information system (CRIStin)
